Astellas mycamine
WebJan 24, 2024 · Astellas reported Mycamine sales of $135 million for the year ending Mar 31, 2024. Shares of Novartis have gained 7.7% in the past year compared with the industry’s increase of 15.5%. Zacks... WebJan 23, 2024 · MYCAMINE ® (Generic Name: micafungin sodium/product name in Japan: FUNGUARD ®) Sales of the product JPY 18.9 billion (fiscal year ended March 31, 2024) …
Astellas mycamine
Did you know?
WebAstellas Stock Replacement Program For Mycamine, a patient assistance program provided by Astellas Pharma Inc., offers Mycamine at no cost to those who are eligible for the program. Eligibility is based off of the following requirements: You must be a citizen of the United States or its Territories. Web3 . Background Drug Information: Mycamine (micafungin) • Therapeutic Category: echinocandin • Sponsor: Astellas Pharma, Inc. • Indication: In adults and pediatric patients 4 months
WebJan 23, 2024 · MYCAMINE ® (Generic Name: micafungin sodium/product name in Japan: FUNGUARD ®) Sales of the product JPY 18.9 billion (fiscal year ended March 31, 2024) Astellas is reviewing potential... WebMar 31, 2024 · Mycamine is indicated for: Adults, adolescents ≥ 16 years of age and elderly treatment of invasive candidiasis; treatment of oesophageal candidiasis in patients for whom intravenous therapy is appropriate;
WebAstellas Pharma US, Inc. announced today the availability of their antifungal agent MYCAMINE® (micafungin sodium) for injection in a 100mg vial format. Approved in 2005 … WebJan 23, 2024 · Astellas Transfers MYCAMINE® Product Worldwide. Published: Jan 23, 2024. TOKYO, Jan. 23, 2024 /PRNewswire/ -- Astellas Pharma US, Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced that Astellas and Sandoz AG ("Sandoz") have entered into an Asset Purchase Agreement, under which …
WebMycamine is indicated for: Treatment of Invasive Candidiasis. Treatment of Esophageal Candidiasis. Prevention of Candida and Aspergillus infections in patients undergoing …
WebAstellas Hong Kong. The Company was established in 1995 with the name of Fujisawa Hong Kong, Ltd., a wholly-owned subsidiary of Fujisawa Taiwan Co., Ltd. Read More. … shelton toys for totsWebJan 24, 2024 · Novartis division Sandoz has entered an agreement to buy the global product rights for the antifungal agent Mycamine (micafungin sodium) from Japanese company Astellas Pharma. Under the agreement, Astellas Pharma will receive an upfront of $62.5m to 75m depending on the transaction closing date, along with milestone payments based … shelton trailer hitchshelton toyotaWebMYCAMINE is contraindicated in persons with known hypersensitivity to micafungin sodium, any component of MYCAMINE, or other echinocandins. (4) WARNINGS AND PRECAUTIONS • • • • • ADVERSE REACTIONS • • To report SUSPECTED ADVERSE REACTIONS, contact Astellas Pharma US, Inc. at 1-800-727-7003 or FDA at 1-800-FDA … sports shelter pop upsWebMycamine: Astellas: Micafungin: Apotex: Used to treat candidemia, acute disseminated candidiasis, and certain other invasive Candida infections, as well as esophageal candidiasis, and prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplantation: shelton tractor swap meetWebCRESEMBA (ISAVUCONAZONIUM SULFATE) FOR INJECTION. LEXISCAN (REGADENOSON) INJECTION. MYCAMINE (MICAFUNGIN SODIUM) FOR INJECTION. MYRBETRIQ. MYRBETRIQ™ (MIRABEGRON FOR ORAL SUSPENSION) GRANULES. PADCEV™ (enfortumab vedotin-ejfv) for injection. PROGRAF (TACROLIMUS) … shelton towersWebJan 8, 2024 · NORTHBROOK, Ill., Jan. 8, 2024 / PRNewswire / -- Astellas Pharma Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for MYCAMINE ® (micafungin for injection) in support of the treatment of Candidemia, Acute Disseminated Candidiasis, Candida … shelton towers hotel nyc